A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice?

Fernando Antonio Glasner da Rocha Araujo; Nairo Massakazu Sumita; Ubirajara Barroso

doi:https://doi.org/10.1590/s1677-5538.ibju.2018.0179

doi.org/10.1590/s1677-5538.ibju.2018.0179

A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice?

Fernando Antonio Glasner da Rocha Araujo

3

,

Nairo Massakazu Sumita

13

,

Ubirajara Barroso

20

International Braz J Urol3.70

Volume: 45, Issue: 3, Pages: 478 - 485

Published: Jun 1, 2019

Abstract

Purpose: To evaluate the trend of use of Prostate Specific Antigen (PSA) for screening of prostate cancer (PC) among Brazilian doctors, from the beginning of its regular availability in clinical laboratories. Material and Methods: A serial cross-sectional study was performed using data obtained from a large database between 1997 and 2016. The general PSA screening trend during this period, adjusted for the total number of exams performed in men,...